Understanding When AI Models Need To Be Validated For Regulated Industries
By Henry Mossi

As artificial intelligence (AI) integrates into regulated life sciences workflows, the focus of validation is shifting from the complexity of the algorithm to the significance of the decision it supports. Regulatory expectations now center on context: how much an outcome depends on AI and the potential impact if that output is wrong. While AI acting as a sole decision-maker requires exhaustive assurance, models used in advisory roles with human oversight allow for a more agile, risk-based approach. By moving away from document-heavy validation toward process-driven assurance, organizations can implement predictive insights and automated reviews without over-validating low-risk scenarios. This strategy prioritizes data governance and targeted testing, ensuring that innovation remains grounded in safety and compliance. Mastering this shift allows leaders to adopt transformative technology faster while maintaining the clear accountability required in a highly regulated environment.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.